{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T02:16:28Z","timestamp":1783304188542,"version":"3.54.6"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["51773098"],"award-info":[{"award-number":["51773098"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R35 GM131728"],"award-info":[{"award-number":["R35 GM131728"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-72589-0","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:06:03Z","timestamp":1777478763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Polyketal-conjugated tafluprost microparticles enable long-acting glaucoma therapy"],"prefix":"10.1038","volume":"17","author":[{"given":"Haiping","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2823-9721","authenticated-orcid":false,"given":"Tuo","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Santamaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6679-2974","authenticated-orcid":false,"given":"Akiva","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7511-3497","authenticated-orcid":false,"given":"Weiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqing","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5215-2829","authenticated-orcid":false,"given":"Changyou","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanzhang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9658-0120","authenticated-orcid":false,"given":"Shuang-Zhuang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoune","family":"Barhoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5369-5932","authenticated-orcid":false,"given":"Daniel S.","family":"Kohane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0916-7451","authenticated-orcid":false,"given":"Shutao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"72589_CR1","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1056\/NEJMra050100","volume":"353","author":"L Osterberg","year":"2005","unstructured":"Osterberg, L. & Blaschke, T. Adherence to medication. N. Engl. J. Med. 353, 487\u2013497 (2005).","journal-title":"N. Engl. J. Med."},{"key":"72589_CR2","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/s41551-021-00698-w","volume":"5","author":"AM Vargason","year":"2021","unstructured":"Vargason, A. M., Anselmo, A. C. & Mitragotri, S. The evolution of commercial drug delivery technologies. Nat. Biomed. Eng. 5, 951\u2013967 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"72589_CR3","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41578-021-00405-w","volume":"7","author":"W Li","year":"2022","unstructured":"Li, W. et al. Clinical translation of long-acting drug delivery formulations. Nat. Rev. Mater. 7, 406\u2013420 (2022).","journal-title":"Nat. Rev. Mater."},{"key":"72589_CR4","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1021\/acs.molpharmaceut.4c00665","volume":"21","author":"S Alidori","year":"2024","unstructured":"Alidori, S., Subramanian, R. & Holm, R. Patient-centric long-acting injectable and implantable platforms\u2500An industrial perspective. Mol. Pharm. 21, 4238\u20134258 (2024).","journal-title":"Mol. Pharm."},{"key":"72589_CR5","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.addr.2016.05.020","volume":"107","author":"BK Lee","year":"2016","unstructured":"Lee, B. K., Yun, Y. & Park, K. PLA micro- and nano-particles. Adv. Drug Deliv. Rev. 107, 176\u2013191 (2016).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"72589_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3390\/pharmaceutics14020359","volume":"14","author":"A Vlachopoulos","year":"2022","unstructured":"Vlachopoulos, A. et al. Poly(lactic acid)-based microparticles for drug delivery applications: an overview of recent advances. Pharmaceutics 14, 359 (2022).","journal-title":"Pharmaceutics"},{"key":"72589_CR7","doi-asserted-by":"publisher","first-page":"114857","DOI":"10.1016\/j.addr.2023.114857","volume":"198","author":"B Wan","year":"2023","unstructured":"Wan, B., Bao, Q. & Burgess, D. Long-acting PLGA microspheres: advances in excipient and product analysis toward improved product understanding. Adv. Drug Deliv. Rev. 198, 114857 (2023).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"72589_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijpharm.2011.05.049","volume":"415","author":"S Fredenberg","year":"2011","unstructured":"Fredenberg, S., Wahlgren, M., Reslow, M. & Axelsson, A. The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems\u2014A review. Int. J. Pharmaceutics 415, 34\u201352 (2011).","journal-title":"Int. J. Pharmaceutics"},{"key":"72589_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0168-3659(98)00123-0","volume":"57","author":"JE Oh","year":"1999","unstructured":"Oh, J. E., Nam, Y. S., Lee, K. H. & Park, T. G. Conjugation of drug to poly (D, L-lactic-co-glycolic acid) for controlled release from biodegradable microspheres. J. Control. Release 57, 269\u2013280 (1999).","journal-title":"J. Control. Release"},{"key":"72589_CR10","doi-asserted-by":"publisher","first-page":"114860","DOI":"10.1016\/j.addr.2023.114860","volume":"198","author":"S-T Chien","year":"2023","unstructured":"Chien, S.-T., Suydam, I. T. & Woodrow, K. A. Prodrug approaches for the development of a long-acting drug delivery systems. Adv. Drug Deliv. Rev. 198, 114860 (2023).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"72589_CR11","doi-asserted-by":"publisher","first-page":"19460","DOI":"10.3390\/molecules191219460","volume":"19","author":"E Oledzka","year":"2014","unstructured":"Oledzka, E. et al. Polylactide conjugates of camptothecin with different drug release abilities. Molecules 19, 19460\u201319470 (2014).","journal-title":"Molecules"},{"key":"72589_CR12","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1080\/03639040801929075","volume":"34","author":"CJ Thompson","year":"2008","unstructured":"Thompson, C. J. et al. Synthesis and evaluation of novel polyester-ibuprofen conjugates for modified drug release. Drug Dev. Ind. Pharm. 34, 877\u2013884 (2008).","journal-title":"Drug Dev. Ind. Pharm."},{"key":"72589_CR13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0168-3659(00)00280-7","volume":"68","author":"HS Yoo","year":"2000","unstructured":"Yoo, H. S., Lee, K. H., Oh, J. E. & Park, T. G. In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin\u2013PLGA conjugates. J. Control. Release 68, 419\u2013431 (2000).","journal-title":"J. Control. Release"},{"key":"72589_CR14","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1080\/026520400417667","volume":"17","author":"C Ustariz-Peyret","year":"2000","unstructured":"Ustariz-Peyret, C., Coudane, J., Vert, M., Kaltsatos, V. & Boisramen\u00e9, B. Labile conjugation of a hydrophilic drug to PLA oligomers to modify a drug delivery system: cephradin in a PLAGA matrix. J. Microencapsul. 17, 615\u2013624 (2000).","journal-title":"J. Microencapsul."},{"key":"72589_CR15","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1021\/acsmacrolett.8b00424","volume":"7","author":"LN Woodard","year":"2018","unstructured":"Woodard, L. N. & Grunlan, M. A. Hydrolytic degradation and erosion of polyester biomaterials. ACS Macro Lett. 7, 976\u2013982 (2018).","journal-title":"ACS Macro Lett."},{"key":"72589_CR16","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1007\/s11095-008-9620-5","volume":"25","author":"EE Falco","year":"2008","unstructured":"Falco, E. E., Patel, M. & Fisher, J. P. Recent developments in cyclic acetal biomaterials for tissue engineering applications. Pharm. Res. 25, 2348\u20132356 (2008).","journal-title":"Pharm. Res."},{"key":"72589_CR17","doi-asserted-by":"publisher","first-page":"6127","DOI":"10.1021\/jacs.6b02435","volume":"138","author":"S Guo","year":"2016","unstructured":"Guo, S. et al. Extended release of native drug conjugated in polyketal microparticles. J. Am. Chem. Soc. 138, 6127\u20136130 (2016).","journal-title":"J. Am. Chem. Soc."},{"key":"72589_CR18","doi-asserted-by":"publisher","first-page":"102552","DOI":"10.1016\/j.cbpa.2024.102552","volume":"84","author":"S Zhao","year":"2025","unstructured":"Zhao, S., Yu, N., Han, H., Guo, S. & Murthy, N. Advances in acid-degradable and enzyme-cleavable linkers for drug delivery. Curr. Opin. Chem. Biol. 84, 102552 (2025).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"72589_CR19","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/S0140-6736(23)01289-8","volume":"402","author":"H Jayaram","year":"2023","unstructured":"Jayaram, H., Kolko, M., Friedman, D. S. & Gazzard, G. Glaucoma: now and beyond.  Lancet 402, 1788\u20131801 (2023).","journal-title":"Lancet"},{"key":"72589_CR20","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.exer.2003.12.007","volume":"78","author":"Y Takagi","year":"2004","unstructured":"Takagi, Y. et al. Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug. Exp. Eye Res. 78, 767\u2013776 (2004).","journal-title":"Exp. Eye Res."},{"key":"72589_CR21","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/s41551-018-0337-4","volume":"3","author":"W Li","year":"2019","unstructured":"Li, W. et al. Rapidly separable microneedle patch for the sustained release of a contraceptive. Nat. Biomed. Eng. 3, 220\u2013229 (2019).","journal-title":"Nat. Biomed. Eng."},{"key":"72589_CR22","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1021\/bc700442g","volume":"19","author":"SC Yang","year":"2008","unstructured":"Yang, S. C., Bhide, M., Crispe, I. N., Pierce, R. H. & Murthy, N. Polyketal copolymers: a new acid-sensitive delivery vehicle for treating acute inflammatory diseases. Bioconjugate Chem. 19, 1164\u20131169 (2008).","journal-title":"Bioconjugate Chem."},{"key":"72589_CR23","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/nmat2299","volume":"7","author":"JC Sy","year":"2008","unstructured":"Sy, J. C. et al. Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction. Nat. Mater. 7, 863\u2013868 (2008).","journal-title":"Nat. Mater."},{"key":"72589_CR24","doi-asserted-by":"publisher","first-page":"4360","DOI":"10.1016\/j.actbio.2014.05.031","volume":"10","author":"Y-H Cheng","year":"2014","unstructured":"Cheng, Y.-H. et al. Sustained delivery of latanoprost by thermosensitive chitosan\u2013gelatin-based hydrogel for controlling ocular hypertension. Acta Biomater. 10, 4360\u20134366 (2014).","journal-title":"Acta Biomater."},{"key":"72589_CR25","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.carbpol.2016.02.080","volume":"144","author":"Y-H Cheng","year":"2016","unstructured":"Cheng, Y.-H. et al. Thermosensitive chitosan-based hydrogel as a topical ocular drug delivery system of latanoprost for glaucoma treatment. Carbohydr. Polym. 144, 390\u2013399 (2016).","journal-title":"Carbohydr. Polym."},{"key":"72589_CR26","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1016\/j.actbio.2014.03.016","volume":"10","author":"M-H Hsiao","year":"2014","unstructured":"Hsiao, M.-H. et al. A temperature-induced and shear-reversible assembly of latanoprost-loaded amphiphilic chitosan colloids: characterization and in vivo glaucoma treatment. Acta Biomater. 10, 3188\u20133196 (2014).","journal-title":"Acta Biomater."},{"key":"72589_CR27","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/ppsc.201400229","volume":"32","author":"RAL Leon","year":"2015","unstructured":"Leon, R. A. L., Somasundar, A., Badruddoza, A. Z. M. & Khan, S. A. Microfluidic fabrication of multi-drug-loaded polymeric microparticles for topical glaucoma therapy. Part. Part. Syst. Charact. 32, 567\u2013572 (2015).","journal-title":"Part. Part. Syst. Charact."},{"key":"72589_CR28","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1021\/ma062319v","volume":"40","author":"R Jain","year":"2007","unstructured":"Jain, R., Standley, S. M. & Fr\u00e9chet, J. M. J. Synthesis and degradation of pH-sensitive linear poly(amidoamine)s. Macromolecules 40, 452\u2013457 (2007).","journal-title":"Macromolecules"},{"key":"72589_CR29","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jconrel.2020.07.022","volume":"326","author":"J Mu","year":"2020","unstructured":"Mu, J. et al. Acid-sensitive PEGylated paclitaxel prodrug nanoparticles for cancer therapy: effect of PEG length on antitumor efficacy. J. Control. Release 326, 265\u2013275 (2020).","journal-title":"J. Control. Release"},{"key":"72589_CR30","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1021\/jacs.6b11181","volume":"139","author":"B Liu","year":"2017","unstructured":"Liu, B. & Thayumanavan, S. Substituent effects on the pH sensitivity of acetals and ketals and their correlation with encapsulation stability in polymeric nanogels. J. Am. Chem. Soc. 139, 2306\u20132317 (2017).","journal-title":"J. Am. Chem. Soc."},{"key":"72589_CR31","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1021\/acs.biomac.9b01493","volume":"21","author":"H Zhong","year":"2020","unstructured":"Zhong, H. et al. Acid-triggered release of native gemcitabine conjugated in polyketal nanoparticles for enhanced anticancer therapy. Biomacromolecules 21, 803\u2013814 (2020).","journal-title":"Biomacromolecules"},{"key":"72589_CR32","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1023\/A:1007582911958","volume":"17","author":"K Fu","year":"2000","unstructured":"Fu, K., Pack, D. W., Klibanov, A. M. & Langer, R. Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm. Res. 17, 100\u2013106 (2000).","journal-title":"Pharm. Res."},{"key":"72589_CR33","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1023\/A:1018876308346","volume":"16","author":"A Shenderova","year":"1999","unstructured":"Shenderova, A., Burke, T. G. & Schwendeman, S. P. The acidic microclimate in poly(lactide-co-glycolide) microspheres stabilizes camptothecins. Pharm. Res. 16, 241\u2013248 (1999).","journal-title":"Pharm. Res."},{"key":"72589_CR34","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.1016\/S0142-9612(02)00170-9","volume":"23","author":"FV Burkersroda","year":"2002","unstructured":"Burkersroda, F. V., Schedl, L. & G\u00f6pferich, A. Why degradable polymers undergo surface erosion or bulk erosion? Biomaterials 23, 4221\u20134231 (2002).","journal-title":"Biomaterials"},{"key":"72589_CR35","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/71916","volume":"18","author":"G Zhu","year":"2000","unstructured":"Zhu, G., Mallery, S. R. & Schwendeman, S. P. Stabilization of proteins encapsulated in injectable poly (lactide- co-glycolide). Nat. Biotechnol. 18, 52\u201357 (2000).","journal-title":"Nat. Biotechnol."},{"key":"72589_CR36","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jconrel.2024.11.046","volume":"377","author":"X Zhou","year":"2025","unstructured":"Zhou, X. et al. Subconjunctival injection of microcrystalline prodrug of dexamethasone for long-acting anti-inflammation after phacoemulsification surgery. J. Control. Release 377, 399\u2013412 (2025).","journal-title":"J. Control. Release"},{"key":"72589_CR37","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.1111\/aos.13983","volume":"97","author":"S Biswas","year":"2019","unstructured":"Biswas, S. & Wan, K. H. Review of rodent hypertensive glaucoma models. Acta Ophthalmol. 97, e331\u2013e340 (2019).","journal-title":"Acta Ophthalmol."},{"key":"72589_CR38","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0079-6123(08)01121-7","volume":"173","author":"JC Morrison","year":"2008","unstructured":"Morrison, J. C., Johnson, E. & Cepurna, W. O. Rat models for glaucoma research. Prog. Brain Res. 173, 285\u2013301 (2008).","journal-title":"Prog. Brain Res."},{"key":"72589_CR39","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/0014-4827(88)90191-7","volume":"175","author":"IA Silver","year":"1988","unstructured":"Silver, I. A., Murrills, R. J. & Etherington, D. J. Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp. Cell Res. 175, 266\u2013276 (1988).","journal-title":"Exp. Cell Res."},{"key":"72589_CR40","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/bph.14327","volume":"176","author":"PG Klimko","year":"2018","unstructured":"Klimko, P. G. & Sharif, N. A. Discovery, characterization and clinical utility of prostaglandin agonists for the treatment of glaucoma. Br. J. Pharmacol. 176, 1051\u20131058 (2018).","journal-title":"Br. J. Pharmacol."},{"key":"72589_CR41","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0169-409X(97)00048-3","volume":"28","author":"JM Anderson","year":"1997","unstructured":"Anderson, J. M. & Shive, M. S. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev. 28, 5\u201324 (1997).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"72589_CR42","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.survophthal.2012.08.010","volume":"58","author":"R Vohra","year":"2013","unstructured":"Vohra, R., Tsai, J. C. & Kolko, M. The role of inflammation in the pathogenesis of glaucoma. Surv. Ophthalmol. 58, 311\u2013320 (2013).","journal-title":"Surv. Ophthalmol."},{"key":"72589_CR43","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1167\/iovs.63.5.2","volume":"63","author":"A Noailles","year":"2022","unstructured":"Noailles, A. et al. Sodium hyaluronate-induced ocular hypertension in rats damages the direction-selective circuit and inner\/outer retinal plexiform layers. Investig. Ophthalmol. Vis. Sci. 63, 2\u20132 (2022).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"72589_CR44","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1007\/s40123-024-00965-4","volume":"13","author":"AM Elhusseiny","year":"2024","unstructured":"Elhusseiny, A. M. & Aref, A. A. Sustained release therapies with the prostaglandin analogues intracameral implants. Ophthalmol. Ther. 13, 1833\u20131839 (2024).","journal-title":"Ophthalmol. Ther."},{"key":"72589_CR45","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1089\/jop.2018.0067","volume":"35","author":"JR Seal","year":"2018","unstructured":"Seal, J. R. et al. Intracameral sustained-release bimatoprost implant delivers bimatoprost to target tissues with reduced drug exposure to off-target tissues. J. Ocul. Pharmacol. Ther. 35, 50\u201357 (2018).","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"72589_CR46","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s40266-020-00769-8","volume":"37","author":"M Shirley","year":"2020","unstructured":"Shirley, M. Bimatoprost implant: first approval. Drugs Aging 37, 457\u2013462 (2020).","journal-title":"Drugs Aging"},{"key":"72589_CR47","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s40265-021-01624-9","volume":"81","author":"J Bacharach","year":"2021","unstructured":"Bacharach, J. et al. Phase 3, randomized, 20-month study of the efficacy and safety of bimatoprost implant in patients with open-angle glaucoma and ocular hypertension (ARTEMIS 2). Drugs 81, 2017\u20132033 (2021).","journal-title":"Drugs"},{"key":"72589_CR48","first-page":"2617","volume":"64","author":"K Battiston","year":"2023","unstructured":"Battiston, K. et al. Tolerability evaluation of RTC-620, a surface eroding bimatoprost acid prodrug intravitreal implant developed for long-term intraocular pressure control. Investig. Ophthalmol. Vis. Sci. 64, 2617\u20132617 (2023).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"72589_CR49","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jconrel.2016.02.041","volume":"228","author":"B Chiang","year":"2016","unstructured":"Chiang, B. et al. Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma. J. Control. Release 228, 48\u201357 (2016).","journal-title":"J. Control. Release"},{"key":"72589_CR50","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1021\/nn4046024","volume":"8","author":"JV Natarajan","year":"2014","unstructured":"Natarajan, J. V. et al. Sustained drug release in nanomedicine: a long-acting nanocarrier-based formulation for glaucoma. ACS Nano 8, 419\u2013429 (2014).","journal-title":"ACS Nano"},{"key":"72589_CR51","doi-asserted-by":"publisher","first-page":"11193","DOI":"10.1021\/acs.nanolett.3c03691","volume":"23","author":"L Qiu","year":"2023","unstructured":"Qiu, L. et al. Dendritic Oligoethylenimine Decorated Liposome with Augmented Corneal Retention and Permeation for Efficient Topical Delivery of Antiglaucoma Drugs. Nano Lett. 23, 11193\u201311202 (2023).","journal-title":"Nano Lett."},{"key":"72589_CR52","unstructured":"Cited available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/211911s000lbl.pdf."},{"key":"72589_CR53","unstructured":"Hopkins, E., Sanvictores, T. & Sharma, S. Physiology, Acid Base Balance (StatPearls Publishing, 2025)."},{"key":"72589_CR54","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1021\/js9802594","volume":"87","author":"MR Prausnitz","year":"1998","unstructured":"Prausnitz, M. R. & Noonan, J. S. Permeability of cornea, sclera, and conjunctiva: A literature analysis for drug delivery to the eye. J. Pharmacol. Sci. 87, 1479\u20131488 (1998).","journal-title":"J. Pharmacol. Sci."},{"key":"72589_CR55","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.exer.2013.04.007","volume":"112","author":"A Giarmoukakis","year":"2013","unstructured":"Giarmoukakis, A. et al. Biodegradable nanoparticles for controlled subconjunctival delivery of latanoprost acid: In vitro and in vivo evaluation. Preliminary results. Exp. Eye Res. 112, 29\u201336 (2013).","journal-title":"Exp. Eye Res."},{"key":"72589_CR56","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/eye.2011.82","volume":"25","author":"E Lavik","year":"2011","unstructured":"Lavik, E., Kuehn, M. H. & Kwon, Y. H. Novel drug delivery systems for glaucoma. Eye 25, 578\u2013586 (2011).","journal-title":"Eye"},{"key":"72589_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25856-1","volume":"12","author":"N Yu","year":"2021","unstructured":"Yu, N. et al. Modular ketal-linked prodrugs and biomaterials enabled by organocatalytic transisopropenylation of alcohols. Nat. Commun. 12, 5532 (2021).","journal-title":"Nat. Commun."},{"key":"72589_CR58","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1124\/dmd.108.024885","volume":"37","author":"Y Fukano","year":"2009","unstructured":"Fukano, Y. & Kawazu, K. Disposition and metabolism of a novel prostanoid antiglaucoma medication, tafluprost, following ocular administration to rats. Drug Metab. Dispos. 37, 1622\u20131634 (2009).","journal-title":"Drug Metab. Dispos."},{"key":"72589_CR59","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jaapos.2003.09.012","volume":"8","author":"SB Ozkan","year":"2004","unstructured":"Ozkan, S. B., Kir, E., Culhaci, N. & Dayanir, V. The effect of Seprafilm on adhesions in strabismus surgery-an experimental study. J. Am. Assoc. Pediatr. Ophthalmol. Strabismus 8, 46\u201349 (2004).","journal-title":"J. Am. Assoc. Pediatr. Ophthalmol. Strabismus"},{"key":"72589_CR60","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10633-022-09872-0","volume":"144","author":"AG Robson","year":"2022","unstructured":"Robson, A. G. et al. ISCEV Standard for full-field clinical electroretinography (2022 update). Doc. Ophthalmol. 144, 165\u2013177 (2022).","journal-title":"Doc. Ophthalmol."},{"key":"72589_CR61","first-page":"692609","volume":"2012","author":"RA Bouhenni","year":"2012","unstructured":"Bouhenni, R. A., Dunmire, J., Sewell, A. & Edward, D. P. Animal models of glaucoma. BioMed. Res. Int. 2012, 692609 (2012).","journal-title":"BioMed. Res. Int."},{"key":"72589_CR62","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1080\/17460441.2023.2246892","volume":"18","author":"R Agarwal","year":"2023","unstructured":"Agarwal, R., Agarwal, P. & Iezhitsa, I. Exploring the current use of animal models in glaucoma drug discovery: where are we in 2023? Expert Opin. Drug Discov. 18, 1287\u20131300 (2023).","journal-title":"Expert Opin. Drug Discov."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72589-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72589-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72589-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T02:01:31Z","timestamp":1783303291000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72589-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["72589"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-72589-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.K. and S.G. are inventors on patent related to drug-polyketal MPs technology (US11071714B2). The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5869"}}